Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo

Adenoviral Conjunctivitis Clinical Trial

Official title:
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Adenoviral Conjunctivitis

Status Terminated

Clinical Trial Summary

The purpose of this study is to determine if an investigational treatment is effective compared with placebo in the treatment of adults and children with adenoviral conjunctivitis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02998554
Study type	Interventional
Source	Takeda
Contact
Status	Terminated
Phase	Phase 3
Start date	March 28, 2017
Completion date	May 16, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01532336` - Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis	Phase 2
Terminated	`NCT02998541` - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo	Phase 3
Completed	`NCT02472223` - Reducing Adenoviral Patient Infected Days	N/A
Terminated	`NCT00901693` - An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis	Phase 2
Withdrawn	`NCT03009799` - Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)	Phase 2
Active, not recruiting	`NCT03856645` - OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis	Phase 2
Completed	`NCT00266734` - Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears	N/A
Completed	`NCT03749317` - Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis	Phase 2